Frequency of Factor V Leiden and Prothrombin Polymorphism in South of Iran

Normal hemostasis requires balanced regulation of prothromboticand antithrombotic factors. Inherited alteration of factor Vand prothrombin gene, the G20210A mutation, increases the resistanceof factor V to degradation and booster production ofprothrombin respectively. These alterations can increase...

Full description

Bibliographic Details
Main Authors: Javad Dehbozorgian, Abdolreza Afrasiabi, Majid Yavarian, Golam Reza Panahandeh Shahraki, Mehran Karimi, Mohammadreza Bordbar, Pier M. Mannucci
Format: Article
Language:English
Published: Shiraz University of Medical Sciences 2009-06-01
Series:Iranian Journal of Medical Sciences
Subjects:
Online Access:http://ijms.sums.ac.ir/files/PDFfiles/34_2_09-Dr_%20Karimi.pdf
_version_ 1818136385374126080
author Javad Dehbozorgian
Abdolreza Afrasiabi
Majid Yavarian
Golam Reza Panahandeh Shahraki
Mehran Karimi
Mohammadreza Bordbar
Pier M. Mannucci
author_facet Javad Dehbozorgian
Abdolreza Afrasiabi
Majid Yavarian
Golam Reza Panahandeh Shahraki
Mehran Karimi
Mohammadreza Bordbar
Pier M. Mannucci
author_sort Javad Dehbozorgian
collection DOAJ
description Normal hemostasis requires balanced regulation of prothromboticand antithrombotic factors. Inherited alteration of factor Vand prothrombin gene, the G20210A mutation, increases the resistanceof factor V to degradation and booster production ofprothrombin respectively. These alterations can increase hypercoagulabilityleading to thrombotic consequences. We aimed toassess the frequencies of these mutations in a group of the populationof southern Iran. In total, 198 healthy volunteers with theage range of 1-64 years were selected and screened for factor VLeiden and prothrombin mutations using polymerase chain reactionand restriction fragment length polymorphism techniques.The carrier frequencies for factor V Leiden and prothrombin mutationin the studied cohort were 4.1% and 3.07%, respectively.In the studied area, the allele frequency of factor V ishigher than the prothrombin G20210A mutation (0.0204 v0.0153). According to the data and Hardy-Weinberger equation,the total risk of thrombosis caused by homozygosity andheterozygosity of factor V Leiden, prothrombin G20210A mutationand compound heterozygosity of these mutations areabout 1 in 500 individuals.
first_indexed 2024-12-11T09:39:34Z
format Article
id doaj.art-2298cf8b0a234ec6af6fcc1e76235518
institution Directory Open Access Journal
issn 0253-0716
1735-3688
language English
last_indexed 2024-12-11T09:39:34Z
publishDate 2009-06-01
publisher Shiraz University of Medical Sciences
record_format Article
series Iranian Journal of Medical Sciences
spelling doaj.art-2298cf8b0a234ec6af6fcc1e762355182022-12-22T01:12:42ZengShiraz University of Medical SciencesIranian Journal of Medical Sciences0253-07161735-36882009-06-01342137140Frequency of Factor V Leiden and Prothrombin Polymorphism in South of IranJavad DehbozorgianAbdolreza AfrasiabiMajid YavarianGolam Reza Panahandeh ShahrakiMehran KarimiMohammadreza BordbarPier M. MannucciNormal hemostasis requires balanced regulation of prothromboticand antithrombotic factors. Inherited alteration of factor Vand prothrombin gene, the G20210A mutation, increases the resistanceof factor V to degradation and booster production ofprothrombin respectively. These alterations can increase hypercoagulabilityleading to thrombotic consequences. We aimed toassess the frequencies of these mutations in a group of the populationof southern Iran. In total, 198 healthy volunteers with theage range of 1-64 years were selected and screened for factor VLeiden and prothrombin mutations using polymerase chain reactionand restriction fragment length polymorphism techniques.The carrier frequencies for factor V Leiden and prothrombin mutationin the studied cohort were 4.1% and 3.07%, respectively.In the studied area, the allele frequency of factor V ishigher than the prothrombin G20210A mutation (0.0204 v0.0153). According to the data and Hardy-Weinberger equation,the total risk of thrombosis caused by homozygosity andheterozygosity of factor V Leiden, prothrombin G20210A mutationand compound heterozygosity of these mutations areabout 1 in 500 individuals.http://ijms.sums.ac.ir/files/PDFfiles/34_2_09-Dr_%20Karimi.pdfFactor V Leidenthrombosismutationprothrombin
spellingShingle Javad Dehbozorgian
Abdolreza Afrasiabi
Majid Yavarian
Golam Reza Panahandeh Shahraki
Mehran Karimi
Mohammadreza Bordbar
Pier M. Mannucci
Frequency of Factor V Leiden and Prothrombin Polymorphism in South of Iran
Iranian Journal of Medical Sciences
Factor V Leiden
thrombosis
mutation
prothrombin
title Frequency of Factor V Leiden and Prothrombin Polymorphism in South of Iran
title_full Frequency of Factor V Leiden and Prothrombin Polymorphism in South of Iran
title_fullStr Frequency of Factor V Leiden and Prothrombin Polymorphism in South of Iran
title_full_unstemmed Frequency of Factor V Leiden and Prothrombin Polymorphism in South of Iran
title_short Frequency of Factor V Leiden and Prothrombin Polymorphism in South of Iran
title_sort frequency of factor v leiden and prothrombin polymorphism in south of iran
topic Factor V Leiden
thrombosis
mutation
prothrombin
url http://ijms.sums.ac.ir/files/PDFfiles/34_2_09-Dr_%20Karimi.pdf
work_keys_str_mv AT javaddehbozorgian frequencyoffactorvleidenandprothrombinpolymorphisminsouthofiran
AT abdolrezaafrasiabi frequencyoffactorvleidenandprothrombinpolymorphisminsouthofiran
AT majidyavarian frequencyoffactorvleidenandprothrombinpolymorphisminsouthofiran
AT golamrezapanahandehshahraki frequencyoffactorvleidenandprothrombinpolymorphisminsouthofiran
AT mehrankarimi frequencyoffactorvleidenandprothrombinpolymorphisminsouthofiran
AT mohammadrezabordbar frequencyoffactorvleidenandprothrombinpolymorphisminsouthofiran
AT piermmannucci frequencyoffactorvleidenandprothrombinpolymorphisminsouthofiran